|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/3955 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/496 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3582811 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18708210.2 |
| Date of filing the European patent application | 2018-02-12 | |
| (97) | Date of publication of the European application | 2019-12-25 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2018/050846 |
| Date | 2018-02-12 |
| (87) | Number | WO 2018/150312 |
| Date | 2018-08-23 |
| (30) | Number | Date | Country code |
| 201762458640 P | 2017-02-14 | US | |
| 201862616682 P | 2018-01-12 | US |
| (72) |
DOBSON, Jason Russell , US
MOODY, Susan , US
MCLAUGHLIN, Margaret Elise , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | DOSING SCHEDULE OF A WNT INHIBITOR AND AN ANTI-PD-1 ANTIBODY MOLECULE IN COMBINATION |
| DOSING SCHEDULE OF A WNT INHIBITOR AND AN ANTI-PD-1 ANTIBODY MOLECULE IN COMBINATION |